478 related articles for article (PubMed ID: 34754620)
1. Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma.
Shang BB; Chen J; Wang ZG; Liu H
PeerJ; 2021; 9():e12315. PubMed ID: 34754620
[TBL] [Abstract][Full Text] [Related]
2. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
3. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining.
Le Y; Kong H; Gao X; Zhu J
Comput Math Methods Med; 2022; 2022():8371885. PubMed ID: 36017155
[TBL] [Abstract][Full Text] [Related]
5. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
[No Abstract] [Full Text] [Related]
6. Identification of KNOP1 as a prognostic marker in hepatocellular carcinoma.
Zhang Y; Wang G; Wang M
Transl Cancer Res; 2023 Jul; 12(7):1684-1702. PubMed ID: 37588747
[TBL] [Abstract][Full Text] [Related]
7. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.
Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061
[TBL] [Abstract][Full Text] [Related]
8. C18ORF54 promotes immune infiltration and poor prognosis as a potential biomarker for hepatocellular carcinoma.
Ma Y; Yan D; Tian F; Song W; Sha R; Shang X; Lv J; Maimaiti N; Kong P; Ma X
Am J Transl Res; 2023; 15(8):5007-5034. PubMed ID: 37692934
[TBL] [Abstract][Full Text] [Related]
9. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Ma C; Kang W; Yu L; Yang Z; Ding T
Front Oncol; 2020; 10():590006. PubMed ID: 33363020
[TBL] [Abstract][Full Text] [Related]
10. Identification and Analysis of Immune-Related Gene Signature in Hepatocellular Carcinoma.
Shen B; Zhang G; Liu Y; Wang J; Jiang J
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292719
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic biomarker:
Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J
Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536
[TBL] [Abstract][Full Text] [Related]
12. EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Liu J; Liu T; Zhang C; He J; Zhou D; Wang Z; Wang R
Front Genet; 2022; 13():992343. PubMed ID: 36276981
[No Abstract] [Full Text] [Related]
13.
Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
Front Oncol; 2021; 11():713017. PubMed ID: 34595113
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of prognostic value and immune cell infiltration of
Hu F; Mei R; Zhang H; Hao D; Li W
Ann Transl Med; 2022 Sep; 10(18):966. PubMed ID: 36267715
[TBL] [Abstract][Full Text] [Related]
15. CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis.
Deng H; Zhang J; Zheng Y; Li J; Xiao Q; Wei F; Han W; Xu X; Zhang Y
Front Surg; 2022; 9():878648. PubMed ID: 36211267
[TBL] [Abstract][Full Text] [Related]
16. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.
Zhang J; Wang Y; Ma J; Aimudula A
Front Oncol; 2023; 13():1163714. PubMed ID: 37483501
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma.
Yang Z; Zhuang L; Szatmary P; Wen L; Sun H; Lu Y; Xu Q; Chen X
Int J Med Sci; 2015; 12(3):256-63. PubMed ID: 25798051
[TBL] [Abstract][Full Text] [Related]
18. The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma.
Wang B; Lan T; Xiao H; Chen ZH; Wei C; Chen LF; Guan JF; Yuan RF; Yu X; Hu ZG; Wu HJ; Dai Z; Wang K
Cancer Cell Int; 2021 May; 21(1):286. PubMed ID: 34059060
[TBL] [Abstract][Full Text] [Related]
19. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
[TBL] [Abstract][Full Text] [Related]
20. HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration.
Ying B; Xu W; Nie Y; Li Y
Dis Markers; 2022; 2022():8446857. PubMed ID: 36452344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]